Come up with a name for your new list and we'll add to it:
InnaVirVax raised a round of funding on July 14, 2008. Investors include
French National Research Agency.
InnaVirVax is a biopharmaceutical company researching and developing therapeutic and diagnostic solutions for diseases linked to the immune system. Through its research on immune dysregulations, the c…